Idexx Laboratories (IDXX) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Idexx Laboratories (IDXX) do?
Idexx Laboratories Inc (IDXX) is a U.S.-listed company in Healthcare (Diagnostics & Research). What it does: Manufactures diagnostic instruments, test kits, and software for companion animal veterinary practices. Installs diagnostic hardware in veterinary clinics to secure recurring sales of proprietary testing consumables and. It is worth $54.33B on the market and sold $4.66B over the last year.
- Market cap
- $54.33B
- P/E ratio
- 46.5×
- Annual sales
- $4.66B
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Brief updated
- Nov 19, 2026
Brands and businesses behind IDXX
- Catalyst: An in-clinic chemistry analyzer that generates recurring revenue from proprietary single-use test slides.
- SNAP: Single-use rapid diagnostic test kits that veterinarians buy continuously to screen pets for heartworm, Lyme, and other diseases.
- ProCyte: An in-clinic hematology analyzer that earns recurring revenue through specialized reagent packs and routine blood counts.
- VetConnect PLUS: A cloud diagnostic software platform that links in-clinic testing and outside reference lab data for animal clinics.
- Colilert: A testing product line that sells enzyme-substrate test packs to municipal utilities for rapid bacterial water screening.
- Cornerstone: A veterinary practice management software system that earns money through software subscriptions and support fees.
IDXX’s flags, in plain English
Each flag is a number from Idexx Laboratories’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.
Earns Its Keep
Earns 68.9% a year on shareholders' money. The company earns a healthy return on the money its shareholders have put in.
Capital Works Hard
Earns 52.2% a year on the money it invests in the business. The money in the business, from shareholders and lenders together, earns a strong return. That points to a company that picks its investments well.
Fat Margins
Profit margin of 25.4%. The company keeps a healthy share of each sale as profit, which gives it room when costs jump.
Priced for Perfection
Priced at 46.5 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
2 more green flags open with the free trial. Try it free for 7 days.
Questions about IDXX
How big is Idexx Laboratories?
Idexx Laboratories’ market cap is $54.33B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $4.66B: what customers paid the company over the last year, before any costs.
What is IDXX’s P/E ratio?
IDXX’s P/E ratio is 46.5×. Investors pay about 46.5 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with IDXX?
A drop in overall veterinary clinic visit volumes reduces demand for consumable diagnostic testing supplies and laboratory processing. That is one risk on Idexx Laboratories’ card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Idexx Laboratories’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. IDXX’s filings on SEC.gov. The Margin Monkey is research, not advice.
